StockData
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

TRINITY BIOTECH PLC

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$8.19+0.16 (+1.99%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

TRINITY BIOTECH PLC revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Trinity Biotech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.